2.1. Study Design
MAY, RECRUITMENT
This study is a single-site parallel feasibility randomised controlled trial (RCT). The study design has the potential to provide information on intervention compliance, retention, adherence, recruitment, and safety [Ethics approvals were obtained in May 2022 from the Deakin University Human Research Ethics Committee (Project Number 2022-041) and Institutional Review Board of the Korle-Bu Teaching Hospital (protocol ID number: KBTH-IRB/00011/2022). The study protocol was also registered with the Australian New Zealand Clinical Trials Registry (registration number: ACTRN12622000323729p). The conduct and reporting of this trial align with the Consolidated Standards of Reporting Trials (CONSORT) guidelines. Individuals provided written consent to participate in this study.There was no a priori sample size calculation as PA programs had not been undertaken previously in Ghana. This project was guided by evidence that feasibility RCTs have a median sample size of 72 (36 per arm) [